Report Detail
Global Newborn Screening for SMA and SCID Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4669976 |
- 22 January, 2026 |
- Global |
- 73 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Newborn Screening for SMA and SCID market size was valued at US$ 188 million in 2025 and is forecast to a readjusted size of US$ 392 million by 2032 with a CAGR of 11.2% during review period.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
This report is a detailed and comprehensive analysis for global Newborn Screening for SMA and SCID market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Newborn Screening for SMA and SCID market size and forecasts, in consumption value ($ Million), 2021-2032
Global Newborn Screening for SMA and SCID market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Newborn Screening for SMA and SCID market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Newborn Screening for SMA and SCID market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Newborn Screening for SMA and SCID
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Newborn Screening for SMA and SCID market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Newborn Screening for SMA and SCID market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Instruments
Kits
Software
Market segment by Application
SCID Screening
SMA Screening
Market segment by players, this report covers
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Newborn Screening for SMA and SCID product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Newborn Screening for SMA and SCID, with revenue, gross margin, and global market share of Newborn Screening for SMA and SCID from 2021 to 2026.
Chapter 3, the Newborn Screening for SMA and SCID competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Newborn Screening for SMA and SCID market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Screening for SMA and SCID.
Chapter 13, to describe Newborn Screening for SMA and SCID research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Newborn Screening for SMA and SCID by Type
- 1.3.1 Overview: Global Newborn Screening for SMA and SCID Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Newborn Screening for SMA and SCID Consumption Value Market Share by Type in 2025
- 1.3.3 Instruments
- 1.3.4 Kits
- 1.3.5 Software
- 1.4 Global Newborn Screening for SMA and SCID Market by Application
- 1.4.1 Overview: Global Newborn Screening for SMA and SCID Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 SCID Screening
- 1.4.3 SMA Screening
- 1.5 Global Newborn Screening for SMA and SCID Market Size & Forecast
- 1.6 Global Newborn Screening for SMA and SCID Market Size and Forecast by Region
- 1.6.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Newborn Screening for SMA and SCID Market Size by Region, (2021-2032)
- 1.6.3 North America Newborn Screening for SMA and SCID Market Size and Prospect (2021-2032)
- 1.6.4 Europe Newborn Screening for SMA and SCID Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Newborn Screening for SMA and SCID Market Size and Prospect (2021-2032)
- 1.6.6 South America Newborn Screening for SMA and SCID Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Newborn Screening for SMA and SCID Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Perkinelmer
- 2.1.1 Perkinelmer Details
- 2.1.2 Perkinelmer Major Business
- 2.1.3 Perkinelmer Newborn Screening for SMA and SCID Product and Solutions
- 2.1.4 Perkinelmer Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Perkinelmer Recent Developments and Future Plans
- 2.2 Thermo Fisher
- 2.2.1 Thermo Fisher Details
- 2.2.2 Thermo Fisher Major Business
- 2.2.3 Thermo Fisher Newborn Screening for SMA and SCID Product and Solutions
- 2.2.4 Thermo Fisher Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Thermo Fisher Recent Developments and Future Plans
- 2.3 ImmunoIVD
- 2.3.1 ImmunoIVD Details
- 2.3.2 ImmunoIVD Major Business
- 2.3.3 ImmunoIVD Newborn Screening for SMA and SCID Product and Solutions
- 2.3.4 ImmunoIVD Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 ImmunoIVD Recent Developments and Future Plans
- 2.4 Labsystems Diagnostics
- 2.4.1 Labsystems Diagnostics Details
- 2.4.2 Labsystems Diagnostics Major Business
- 2.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Product and Solutions
- 2.4.4 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Labsystems Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Newborn Screening for SMA and SCID Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Newborn Screening for SMA and SCID by Company Revenue
- 3.2.2 Top 3 Newborn Screening for SMA and SCID Players Market Share in 2025
- 3.2.3 Top 6 Newborn Screening for SMA and SCID Players Market Share in 2025
- 3.3 Newborn Screening for SMA and SCID Market: Overall Company Footprint Analysis
- 3.3.1 Newborn Screening for SMA and SCID Market: Region Footprint
- 3.3.2 Newborn Screening for SMA and SCID Market: Company Product Type Footprint
- 3.3.3 Newborn Screening for SMA and SCID Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Newborn Screening for SMA and SCID Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Newborn Screening for SMA and SCID Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Newborn Screening for SMA and SCID Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Newborn Screening for SMA and SCID Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Newborn Screening for SMA and SCID Consumption Value by Type (2021-2032)
- 6.2 North America Newborn Screening for SMA and SCID Market Size by Application (2021-2032)
- 6.3 North America Newborn Screening for SMA and SCID Market Size by Country
- 6.3.1 North America Newborn Screening for SMA and SCID Consumption Value by Country (2021-2032)
- 6.3.2 United States Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 6.3.3 Canada Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Newborn Screening for SMA and SCID Consumption Value by Type (2021-2032)
- 7.2 Europe Newborn Screening for SMA and SCID Consumption Value by Application (2021-2032)
- 7.3 Europe Newborn Screening for SMA and SCID Market Size by Country
- 7.3.1 Europe Newborn Screening for SMA and SCID Consumption Value by Country (2021-2032)
- 7.3.2 Germany Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 7.3.3 France Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 7.3.5 Russia Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 7.3.6 Italy Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region
- 8.3.1 Asia-Pacific Newborn Screening for SMA and SCID Consumption Value by Region (2021-2032)
- 8.3.2 China Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 8.3.3 Japan Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 8.3.5 India Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 8.3.7 Australia Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Newborn Screening for SMA and SCID Consumption Value by Type (2021-2032)
- 9.2 South America Newborn Screening for SMA and SCID Consumption Value by Application (2021-2032)
- 9.3 South America Newborn Screening for SMA and SCID Market Size by Country
- 9.3.1 South America Newborn Screening for SMA and SCID Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country
- 10.3.1 Middle East & Africa Newborn Screening for SMA and SCID Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
- 10.3.4 UAE Newborn Screening for SMA and SCID Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Newborn Screening for SMA and SCID Market Drivers
- 11.2 Newborn Screening for SMA and SCID Market Restraints
- 11.3 Newborn Screening for SMA and SCID Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Newborn Screening for SMA and SCID Industry Chain
- 12.2 Newborn Screening for SMA and SCID Upstream Analysis
- 12.3 Newborn Screening for SMA and SCID Midstream Analysis
- 12.4 Newborn Screening for SMA and SCID Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Newborn Screening for SMA and SCID. Industry analysis & Market Report on Newborn Screening for SMA and SCID is a syndicated market report, published as Global Newborn Screening for SMA and SCID Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Newborn Screening for SMA and SCID market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
